
Related news and events
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
Experience
MannKind to Acquire scPharmaceuticals for up to $360 Million
August 25, 2025
Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on its definitive merger agreement to acquire scPharmaceuticals for up to $360 million
Related contacts
Related Practices & Industries
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
August 7, 2025
Cooley advised a syndicate of globally recognized private and public investors in connection with the management-led majority stake acquisition of HistoSonics, the developer of the Edison Histotripsy System and novel histotripsy therapy platform, valuing the company at approximately $2.25 billion.
Related contacts
Related Practices & Industries
Y-mAbs Therapeutics Agrees to Acquisition by SERB Pharmaceuticals
August 5, 2025
Cooley advised Y-mAbs Therapeutics, a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody-based therapeutics for the treatment of cancer, on its definitive merger agreement with SERB Pharmaceuticals. Under the agreement, SERB will acquire Y-mAbs, including its lead commercial oncology asset, DANYELZA, in an all-cash transaction representing an equity value of approximately $412 million.
Related contacts
Related Practices & Industries
Contentsquare Enters Definitive Agreement to Acquire Loris AI
July 30, 2025
Cooley advised Contentsquare, an all-in-one experience intelligence platform, on its definitive agreement to acquire Loris AI, a conversation intelligence platform, to give business leaders a deeper, more accurate view of the full customer journey – from click to conversation.
Related contacts
Related Practices & Industries
Cooley Advises io Products on $6.5 Billion Acquisition by OpenAI
May 29, 2025
Cooley advised io Products, an engineering and product manufacturing company co-founded by Jony Ive to develop, engineer and manufacture a new family of products for the artificial general intelligence era, on its approximately $6.5 billion acquisition by OpenAI. As part of the deal, Ive and his creative collective, LoveFrom, will assume deep design and creative responsibilities across OpenAI.
Related contacts
Related Practices & Industries
Admissions and credentials
New York